
CAS: 2704617-96-7
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | BRD9 Related Compound 9 REF: 4Z-B-248009CAS: 2704617-96-7 | - - - | To inquire | Tue 25 Mar 25 |
![]() | CFT8634 REF: TM-T73425CAS: 2704617-96-7 | - - - | 265.00 €~4,370.00 € | Tue 17 Jun 25 |

Ref: 4Z-B-248009
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 25 Mar 2025

CFT8634
CAS:2704617-96-7
CFT8634 degrades BRD9, for synovial sarcoma and SMARCB1 tumor research, from patent WO2021178920A1.
Formula:
C37H45F3N6O5
Color and Shape:
Liquid
Molecular weight:
710.79
Ref: TM-T73425
1mg | 265.00 € | ||
5mg | 645.00 € | ||
10mg | 1,017.00 € | ||
25mg | 1,882.00 € | ||
50mg | 3,030.00 € | ||
100mg | 4,370.00 € |
Estimated delivery in United States, on Tuesday 17 Jun 2025